Novakand Pharma AB (publ) (LARK) — Financial Flexibility Index
Novakand Pharma AB (publ) (LARK) has a Financial Flexibility Index of 0.42x as of June 2026. Free cash flow of Skr352.00K (operating CF Skr352.00K minus capex Skr0.00) represents 0% of total liabilities (Skr846.00K). Explore LARK capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Novakand Pharma AB (publ) Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Novakand Pharma AB (publ) across 14 annual periods. Check how aggressively does Novakand Pharma AB (publ) reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Financial Flexibility Index for Novakand Pharma AB (publ) (2012–2025)
Year-by-year free cash flow to debt coverage for Novakand Pharma AB (publ). For the full cash flow conversion analysis, see LARK cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -10.31x | Skr-12.78 Million | Skr-12.78 Million | Skr1.24 Million | ▼ -48.1% |
| 2024 | -6.96x | Skr-29.95 Million | Skr-29.95 Million | Skr4.30 Million | ▲ +4.9% |
| 2023 | -7.33x | Skr-30.45 Million | Skr-30.56 Million | Skr4.16 Million | ▼ -168.1% |
| 2022 | -2.73x | Skr-16.67 Million | Skr-16.67 Million | Skr6.10 Million | ▼ -197.5% |
| 2021 | 2.80x | Skr22.26 Million | Skr22.11 Million | Skr7.94 Million | ▲ +158.5% |
| 2020 | -4.79x | Skr-38.24 Million | Skr-38.35 Million | Skr7.98 Million | ▼ -421.5% |
| 2019 | -0.92x | Skr-21.60 Million | Skr-21.60 Million | Skr23.51 Million | ▼ -2147.8% |
| 2018 | 0.04x | Skr657.80K | Skr227.60K | Skr14.66 Million | ▲ +100.8% |
| 2017 | -5.86x | Skr-9.53 Million | Skr-9.53 Million | Skr1.63 Million | ▲ +45.7% |
| 2016 | -10.78x | Skr-8.73 Million | Skr-8.81 Million | Skr809.66K | ▼ -24.6% |
| 2015 | -8.65x | Skr-5.99 Million | Skr-6.29 Million | Skr691.73K | ▼ -711.4% |
| 2014 | -1.07x | Skr-620.67K | Skr-620.67K | Skr582.04K | ▲ +83.9% |
| 2013 | -6.64x | Skr-272.15K | Skr-272.15K | Skr40.98K | ▼ -3426.4% |
| 2012 | 0.20x | Skr59.21K | Skr59.21K | Skr296.58K | — |